Signal #135471 · SEC 8-K

$CTXR SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $CTXR filing catalyst

Why did $CTXR trigger an AI stock catalyst alert?

$CTXR triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +2.5/10). Headline: Citius Oncology Presents Positive Quality of Life Data for LYMPHIR at EORTC-CLTG. Key points: - 32% of heavily pretreated patients achieved clinically meaningful itch reduction sustained for four weeks or longer in Study 302. - Presentation delivered at the EORTC-CLTG 2026 Annual Meeting in Berlin. - Data supports the commercial profile of LYMPHIR in r/r cutaneous T-cell lymphoma.

How did $CTXR stock react after the SEC filing?

After the SEC 8-K for $CTXR, observed market reaction: T0 price $0.55. Past moves do not guarantee future results.

Where can I get real-time $CTXR SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $CTXR via Telegram and the VIP Web Terminal from €10/month.

$CTXR

$CTXR – Citius Oncology Presents Positive Quality of Life Data for LYMPHIR at EORTC-CLTG

Citius Pharmaceuticals, Inc.

2026-11-04 00:00:00 UTC · SEC 8-K · All $CTXR

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+2.5 / 10)

32% of heavily pretreated patients achieved clinically meaningful itch reduction sustained for four weeks or longer in Study 302.
Presentation delivered at the EORTC-CLTG 2026 Annual Meeting in Berlin.
Data supports the commercial profile of LYMPHIR in r/r cutaneous T-cell lymphoma.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →